ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $35,283,000 | +40.3% | 379,629 | -10.1% | 0.01% | +75.0% |
| Q3 2021 | $25,146,000 | +472.9% | 422,272 | +556.2% | 0.00% | – |
| Q2 2021 | $4,389,000 | -81.5% | 64,351 | -81.2% | 0.00% | -100.0% |
| Q1 2021 | $23,747,000 | +160.3% | 342,224 | +188.2% | 0.01% | +100.0% |
| Q4 2020 | $9,124,000 | -32.6% | 118,745 | -34.4% | 0.00% | 0.0% |
| Q3 2020 | $13,536,000 | -80.1% | 180,993 | -83.2% | 0.00% | -88.0% |
| Q2 2020 | $68,004,000 | +23.3% | 1,080,280 | -17.7% | 0.02% | +4.2% |
| Q1 2020 | $55,146,000 | +88.8% | 1,312,995 | +104.2% | 0.02% | +84.6% |
| Q4 2019 | $29,202,000 | +15.8% | 642,944 | +16.6% | 0.01% | +8.3% |
| Q3 2019 | $25,227,000 | -10.2% | 551,179 | +15.0% | 0.01% | -7.7% |
| Q2 2019 | $28,092,000 | -22.8% | 479,151 | -41.0% | 0.01% | -27.8% |
| Q1 2019 | $36,398,000 | -7.0% | 811,909 | -19.2% | 0.02% | -18.2% |
| Q4 2018 | $39,144,000 | +19.0% | 1,004,983 | +40.6% | 0.02% | +46.7% |
| Q3 2018 | $32,899,000 | +31.4% | 714,878 | +24.5% | 0.02% | +25.0% |
| Q2 2018 | $25,038,000 | +36.7% | 574,259 | +23.9% | 0.01% | +20.0% |
| Q1 2018 | $18,310,000 | -44.8% | 463,537 | -52.6% | 0.01% | -50.0% |
| Q4 2017 | $33,191,000 | +82.3% | 977,069 | +36.9% | 0.02% | +42.9% |
| Q3 2017 | $18,202,000 | +1424.5% | 713,824 | +908.4% | 0.01% | +1300.0% |
| Q2 2017 | $1,194,000 | – | 70,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |